Dragon Pharma Vesilute is a synthetic peptide bioregulator developed as part of the Khavinson peptide family, specifically designed for research into bladder function and urinary tract health. It is believed to work at the epigenetic level, regulating gene expression related to bladder tissue, detrusor muscle function, and urinary tract integrity. This organ-specific peptide is studied for its potential to support bladder function, maintain urinary tract health, and promote urological well-being in research models.
If you're looking for legit Vesilute for research purposes, this peptide is part of the comprehensive Khavinson bioregulator system — alongside Epitalon (pineal), Livagen (liver), Testagen (testicular), Ovagen (ovarian), and other organ-specific peptides. For researchers studying bladder physiology, urinary tract function, or urological health, Vesilute offers a targeted bioregulatory tool worth exploring.
Bladder and urinary tract health can be affected by intense training, hydration practices, and age-related changes. Vesilute research focuses on its potential to support bladder tissue function, detrusor muscle integrity, and urinary tract health. For researchers studying the impact of training on urological health or age-related bladder changes, Vesilute offers a targeted peptide bioregulator approach distinct from conventional interventions.
Important: This product is for laboratory research purposes only. Not for human or veterinary use. Lab test reports for this batch are coming soon — check back for third-party purity verification.
Note for researchers: Vesilute is a Khavinson bioregulator peptide with a proposed epigenetic mechanism. For best results in your research, follow established protocols and always source Vesilute from verified suppliers like Dragon Pharma.
For laboratory research use only. Vesilute is a bladder peptide bioregulator for urological research. Proper reconstitution, dosing accuracy, and research protocols are essential. Not for human or veterinary use.
Vesilute comes as a lyophilized powder in a 2 mL sterile vial. You'll need bacteriostatic water to reconstitute it properly.
Need bacteriostatic water for your research? Get it here →
Based on available research literature (including Khavinson studies), typical Vesilute dosing in animal models falls in this range:
Using a standard 1 mL (100 unit) insulin syringe with Vesilute reconstituted to 10 mg/mL:
Vesilute is part of the Khavinson peptide bioregulator family, designed for organ-specific research on bladder and urinary tract function. It is studied for its potential to support bladder health, urinary tract integrity, and urological function.
Popular research stacks include:
Research Note: Individual responses vary in animal models. Keep a research log, track observations, and adjust protocols based on your specific research goals. Always follow institutional and laboratory safety guidelines.
At Dragon Pharma, every batch of Vesilute is scheduled for independent third-party HPLC testing to verify purity, mass, and sterility. The report for the current batch is in progress and will be published here as soon as it's available.
📄 Lab Report Status: In progress — expected within 2–3 weeks. All verified customers will be notified via email when the COA is published.
With the rise of counterfeit research peptides, independent lab verification is the only way to confirm you're getting what you paid for. Vesilute should meet strict purity and mass standards. Dragon Pharma commits to full transparency — as soon as each batch is tested, the COA will appear here with:
For more information on Vesilute research and peptide bioregulators, refer to this PubMed study on Khavinson peptide bioregulators.
The lab report for Dragon Pharma Vesilute (20 mg) will be displayed here once testing is complete.
🔬 Want to be notified when the lab report is available? Sign up for batch updates or check back on this page. All batches are tracked and verified through our system to ensure you receive nothing but genuine Dragon Pharma products.
All Dragon Pharma Vesilute orders ship directly from authorized distribution points. Outer packaging is discreet with no mention of product contents — just a plain box with a shipping label. Your privacy and security are priorities.
Counterfeit research peptides are a real problem. Here's how to confirm you're getting authentic Dragon Pharma Vesilute:
⚠️ Important: Only purchase from authorized sources. If a deal seems too good to be true, it probably is. Fake Vesilute may contain incorrect compounds, incorrect dosages, or harmful impurities. Always verify before using in research.
For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.
Dragon Pharma Vesilute is a lyophilized (freeze-dried) peptide. Proper storage is critical to maintain peptide integrity, purity, and research validity.
Before using in your research, always inspect the vial:
⚠️ Research note: Degraded peptides can produce unreliable research results. If you suspect your Vesilute has been stored improperly (warm shipping, left out of fridge, expired), do not use it in critical research. Contact support for batch verification.
Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research peptides.
Vesilute is a synthetic peptide bioregulator developed as part of the Khavinson peptide family, specifically designed for research into bladder function and urinary tract health. It is believed to work at the epigenetic level, regulating gene expression related to bladder tissue, detrusor muscle function, and urinary tract integrity. Like other Khavinson peptides, it is proposed to restore the functional activity of target cells — in this case, bladder and urinary tract cells — through epigenetic mechanisms.
Yes. Dragon Pharma Vesilute is manufactured under strict quality standards with batch traceability, QR code verification, and third-party lab testing (report coming soon). To ensure you receive legit Vesilute, always verify the scratch-off code on the box through Dragon Pharma's official verification system before using in research.
Add 2 mL of bacteriostatic water to the 20 mg vial. Gently swirl — do not shake. Final concentration = 10 mg per mL. Store reconstituted peptide in the refrigerator and use within 14 days. Need bacteriostatic water? Shop here →
Based on available research (including Khavinson studies), typical dosing ranges from 5–20 mg per day. Using a 1 mL insulin syringe with 10 mg/mL concentration: 0.10 mL (10 units) = 1 mg, 0.25 mL (25 units) = 2.5 mg, 0.50 mL (50 units) = 5 mg, 1.00 mL (100 units) = 10 mg. One 20 mg vial provides approximately 1-4 research doses depending on dose. Classical protocol follows the Khavinson bioregulator course: 10 mg daily for 10 days.
Khavinson peptides are a family of short peptide bioregulators developed by Professor Vladimir Khavinson. They are designed to be organ-specific, regulating gene expression in targeted tissues through epigenetic mechanisms. Vesilute is for bladder research, Epitalon for pineal gland, Livagen for liver, Testagen for testicular, Ovagen for ovaries, and other peptides exist for different organs. These peptides are well-studied in Russian research literature for their potential effects on organ function and aging.
Many researchers stack Vesilute with other Khavinson peptides or urological research compounds. Common stacks include Epitalon for comprehensive bioregulation research, Testagen for urological and reproductive studies, or BPC 157 for tissue repair research. Always follow proper research protocols and safety guidelines when stacking.
Before reconstitution: store lyophilized powder at 2–8°C (refrigerator). Do not freeze. After reconstitution: keep refrigerated at 2–8°C and use within 14 days. Never freeze after mixing — it damages the peptide. Keep away from light and heat.
Each Dragon Pharma Vesilute vial contains 20 mg of lyophilized peptide. At 5 mg per day, one vial lasts approximately 4 days. At 10 mg per day (classic Khavinson protocol), it lasts 2 days. Most research courses require 5-10 vials depending on protocol length.
Neither. Vesilute is a research peptide for laboratory use only. It is not approved by the FDA for human or veterinary use. Dragon Pharma sells this product strictly for research purposes, including in-vitro studies and controlled laboratory research.
You're in the right place. Dragon Pharma Vesilute is available for research purposes with USA domestic and international shipping. Every batch is scheduled for third-party testing with results published once available. Always verify authenticity using the QR code on your box. Avoid third-party resellers — purchase directly from authorized Dragon Pharma distributors to ensure you receive legit Vesilute.
Still have questions? Contact our support team for research-related inquiries. For specific medical or clinical advice, consult with qualified professionals.
Please log in to write Vesilute 20 mg review.